Showing results (111-120 of 232) with videos related to
Sort By:
Pageof 24
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|June 14, 2003
TNF-alpha and growth hormone resistance in patients with chronic liver diseaseAntonio Picardi, Umberto Vespasiani Gentilucci, Enrico Maria Zardi, et al.The Journal of Clinical Endocrinology and Metabolism|July 3, 2020
The Vicious Circle of Left Ventricular Dysfunction and Diabetes: From Pathophysiology to Emerging TreatmentsIlaria Cavallari, Ernesto Maddaloni, Silvia Pieralice, et al.Diabetes, Obesity & Metabolism|June 9, 2022
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspectiveErnesto Maddaloni, Geremia B Bolli, Brian M Frier, et al.Diabetes, Obesity & Metabolism|March 16, 2017
Placebo-controlled, randomized trial of the addition of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide to titrated daily insulin glargine in patients with type 2 diabetes (AWARD-9)Paolo Pozzilli, Paul Norwood, Esteban Jódar, et al.Archives of Internal Medicine|November 10, 2010
Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES)Stefano Balducci, Silvano Zanuso, Antonio Nicolucci, et al.Journal of the American College of Nutrition|July 7, 2011
Dietary pattern and bone density changes in elderly women: a longitudinal studyClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.Current Diabetes Reports|October 30, 2018
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in DiabetesIlaria Cavallari, Alessia Delli Veneri, Ernesto Maddaloni, et al.Rejuvenation Research|July 9, 2013
Bone health as a function of adipokines and vitamin D pattern in elderly patientsClaudio Pedone, Nicola Napoli, Paolo Pozzilli, et al.Diabetes Care|July 12, 2014
Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetesRonnie Aronson, Peter A Gottlieb, Jens S Christiansen, et al.Plos One|February 26, 2013
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetesNicola Napoli, Rocky Strollo, Dario Pitocco, et al.Pageof 24